<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz / lillymark / tag / clinical</title>
<link>http://netvouz.com/lillymark/tag/clinical?feed=rss&amp;pg=3</link>
<description>lillymark&#39;s bookmarks tagged &quot;clinical&quot; on Netvouz</description>
<item><title>Clinical Trials..</title>
<link>http://mywikibiz.com/Clinical_Trials</link>
<description>Renewed threats from disease, fresh challenges from debilitating conditions and the scourge of pandemics demand rapid responses and concerted efforts on a global scale.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 22 Feb 2013 07:18:43 GMT</pubDate>
</item><item><title>CRO’s help in Medical Innovation and Drug Development</title>
<link>http://goarticles.com/article/CRO-S-Help-in-Medical-Innovation-and-Drug-Development/8404203/</link>
<description>Serious medical conditions like the new threats that result from chronic ailments and their critical conditions need fast responses and continuous attempts in a huge scale and on a global level.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Wed, 05 Feb 2014 08:16:33 GMT</pubDate>
</item><item><title>DCGI not to approve BA/BE studies conducted at clinical or bioanalytical facilities not approved by CDSCO</title>
<link>http://www.lotuslabs.com/Uploads/English/News%20Letter/Pdf/LOTUS_LABS_NEWS_LETTER_FEBRUARY_2014.pdf</link>
<description>The drug controller general of India (DCGI) will not accept and approve the reports of bioavailability (BA) and bioequivalence (BE) studies which are conducted at clinical or bioanalytical facilities that are not approved by the Central Drugs Standard Control Organisation (CDSCO).</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Wed, 04 Jun 2014 10:52:02 GMT</pubDate>
</item><item><title>Effective Drug Development with Phase 1 Study Programs</title>
<link>http://www.articlesnatch.com/Article/Effective-Drug-Development-with-Phase-1-Study-Programs/4533464#.UYx2NbVTAjc</link>
<description>Phase 1 Studies are an essential aspect of drug development processes as they provide the first scope for attaining data for an investigational product concerning its security, clinical pharmacokinetics as well as pharmacodynamics in humans.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 10 May 2013 04:52:14 GMT</pubDate>
</item><item><title>Essential Aspects that Influence Contemporary Clinical Trials</title>
<link>http://www.slideshare.net/LotusLabs/essential-aspects-that-influence-contemporary-clinical-trials</link>
<description>To explain in simple terms, clinical trials are important steps to arrive at a new treatment procedure for severe diseases.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 27 Dec 2013 05:15:00 GMT</pubDate>
</item><item><title>Essential Components of Clinical Trials</title>
<link>http://www.articlesnatch.com/Article/Essential-Components-of-Clinical-Trials/4480456</link>
<description>Clinical trials can be defined as a set of drug development and medical research procedures that generate data efficacy and safety.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 05 Apr 2013 05:14:09 GMT</pubDate>
</item><item><title>European Commission issues GDP norms,Indian pharma conform to new rules</title>
<link>http://www.lotuslabs.com/Uploads/English/News%20Letter/Pdf/LOTUS_LABS_NEWS_LETTER_JANUARY_2014.pdf</link>
<description>European Commission has issued a guidance on Good Distribution Practice (GDP) of edicinal products for human use. Indian pharma companies see the new norms would transform the pharma marketing in the region.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 06 Jun 2014 10:13:09 GMT</pubDate>
</item><item><title>Functions of Regulatory Compliance Services in CRO’s</title>
<link>http://www.slideshare.net/LotusLabs/functions-of-regulatory-compliance-services-in-cros</link>
<description>The Indian subcontinent in the last decade has witnessed multiple developments and advancements in clinical trials and in data and project management.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Thu, 05 Dec 2013 06:44:33 GMT</pubDate>
</item><item><title>High-End Biometrics Service Portfolio</title>
<link>http://www.articlesnatch.com/Article/High-End-Biometrics-Service-Portfolio/4428692#.URiqbx32-Tw</link>
<description>Biometrics are also described as biometric authentication and includes processes for recognizing humans related to one or more inherent behavioral traits.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Mon, 18 Mar 2013 07:44:26 GMT</pubDate>
</item><item><title>How Does Clinical Laboratory Services Help in Clinical Trials?</title>
<link>http://mywikibiz.com/How_Does_Clinical_Laboratory_Services_Help_in_Clinical_Trials%3F</link>
<description>A clinical research is incomplete without a clinical laboratory. Simply put, a clinical laboratory recognizes the chemical composition in blood samples and urine.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 27 Dec 2013 06:25:54 GMT</pubDate>
</item></channel></rss>